Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
53.5M
-
Shares change
-
+237K
-
Total reported value, excl. options
-
$1.09B
-
Value change
-
+$7.58M
-
Put/Call ratio
-
0.8
-
Number of buys
-
40
-
Number of sells
-
-49
-
Price
-
$20.41
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q1 2021
123 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q1 2021.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.5M shares
.
Largest 10 shareholders include FMR LLC (9.73M shares), BAUPOST GROUP LLC/MA (8.74M shares), WELLINGTON MANAGEMENT GROUP LLP (7.46M shares), ORBIMED ADVISORS LLC (6.22M shares), BlackRock Inc. (4.63M shares), VANGUARD GROUP INC (4.52M shares), STATE STREET CORP (1.15M shares), Chescapmanager LLC (1.13M shares), GEODE CAPITAL MANAGEMENT, LLC (838K shares), and Laurion Capital Management LP (705K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.